Detailed Multi-Method Analysis of Bone Marrow from Pediatric Pre-B-ALL Patients Prior to CD19-CAR-T Therapy Subsequently Evidencing Overt CAR-T ResistanceKatherine E. Masih, Rimas J. Orentas, Michael C. Kelly et al.|Blood|2019Cited by 3
Abstract LB-056: An integrated genomic, epigenetic, proteomic, and single cell analysis of pediatric B cell acute lymphoblastic leukemia to elucidate resistance mechanisms to CD19 CAR T cell therapyKatherine E. Masih, Javed Khan, Rebecca Gardner et al.|Immunology|2019Cited by 0
Abstract A11: A comprehensive and integrative omic analysis of multiply relapsed refractory pediatric pre-B cell acute lymphoblastic leukemia predicts response to CD19 CAR T-cell therapyKatherine E. Masih, Javed Khan, Rebecca Gardner et al.|Cancer Research|2020Cited by 0
Abstract LB-141: Increased epigenetic plasticity and tumor heterogeneity predict resistance to CD19 CAR T cell therapy in pre-treatment pediatric acute lymphoblastic leukemiaKatherine E. Masih, Rimas J. Orentas, Abdalla Abdelmaksoud et al.|Cancer Research|2020Cited by 0
Abstract LB-056: An integrated genomic, epigenetic, proteomic, and single cell analysis of pediatric B cell acute lymphoblastic leukemia to elucidate resistance mechanisms to CD19 CAR T cell therapyKatherine E. Masih, Javed Khan, Rebecca Gardner et al.|Cancer Research|2019Cited by 0